Man Group plc Buys New Stake in Siga Technologies Inc. $SIGA

Man Group plc bought a new stake in Siga Technologies Inc. (NASDAQ:SIGA) during the second quarter, HoldingsChannel reports. The institutional investor bought 157,348 shares of the company’s stock, valued at approximately $573,000.

Other hedge funds have also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its position in Siga Technologies by 418.1% in the 4th quarter. Farther Finance Advisors LLC now owns 4,150 shares of the company’s stock valued at $25,000 after acquiring an additional 3,349 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Siga Technologies by 34.1% in the second quarter. BNP Paribas Financial Markets now owns 4,661 shares of the company’s stock valued at $30,000 after purchasing an additional 1,184 shares during the period. CWM LLC grew its stake in Siga Technologies by 148.6% during the 4th quarter. CWM LLC now owns 5,027 shares of the company’s stock worth $31,000 after purchasing an additional 3,005 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in Siga Technologies by 116.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,817 shares of the company’s stock worth $44,000 after purchasing an additional 3,669 shares during the period. Finally, Parallel Advisors LLC raised its position in Siga Technologies by 47.0% in the 4th quarter. Parallel Advisors LLC now owns 7,969 shares of the company’s stock valued at $49,000 after purchasing an additional 2,549 shares in the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.

Siga Technologies Price Performance

NASDAQ:SIGA opened at $3.23 on Friday. Siga Technologies Inc. has a 12 month low of $2.83 and a 12 month high of $9.45. The firm has a market capitalization of $232.08 million, a PE ratio of -64.60 and a beta of 0.97. The business’s fifty day moving average price is $3.29 and its 200 day moving average price is $4.39.

Siga Technologies (NASDAQ:SIGA) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.17 EPS for the quarter. The business had revenue of $41.00 million for the quarter. Siga Technologies had a negative return on equity of 1.55% and a negative net margin of 5.19%.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Siga Technologies from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Siga Technologies Profile

Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.

Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.